Validation of a genomic classifier that predicts metastatic disease progression in men with high-risk pathologic features postprostatectomy.

作者
Mercedeh Ghadessi,Eric J. Bergstralh,Nicholas Erho,Anamaria Crisan,Elai Davicioni,Christine Buerki,Anirban Pradip Mitra,Darby J. S. Thompson,Rachel E. Carlson,Zaid Haddad,Benedikt Zimmermann,Karla V. Ballman,Thomas M. Kollmeyer,Thomas Sierocinski,Ismael A. Vergara,Timothy Junius Triche,Peter C. Black,Robert Houston Thompson,Robert Jeffrey Karnes,Robert Brian Jenkins
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:31 (6_suppl): 36-36 被引量:2
标识
DOI:10.1200/jco.2013.31.6_suppl.36
摘要

36 Background: Following radical prostatectomy (RP), 30-40% of patients have adverse pathology and are deemed at high risk for metastatic progression. The objective of this study was to validate the ability of Decipher, a genomic classifier (GC), to improve prediction of metastatic disease progression compared with clinical variables in order to better identify candidates for therapy intensification. Methods: A previously developed 22-feature GC model was validated in a prospectively designed case-cohort study of a clinically high-risk population (i.e., with one or more adverse pathological features) of 1,010 RP patients treated at Mayo Clinic between 2000-2006. A random sample of 20% of the cohort was subjected to microarray analysis and GC scores were generated for 219 patients. The primary endpoint, the c-index for predicting metastatic disease progression (i.e., positive bone or CT scans) was evaluated in a blinded analysis. Cox modeling and decision curve analyses were used to compare the performance of GC to individual clinical variables and prediction models. Results: GC had a c-index 0.79 (95% CI 0.71-0.86) that was significantly better than any single clinical variable. Cumulative incidence curves in the cohort showed that 72% of patients had low GC scores with only 3% and 6% incidence of metastatic disease at 5 and 10 years post RP. In contrast, for the 28% of patients with high GC scores, the cumulative incidence was 17% and 25% at 5 and 10 years post RP. Decision curve analysis showed that the GC model had higher overall net benefit compared to clinical variables over a wide range of ‘decision-to-treat’ thresholds for risk of metastasis. In multivariable modeling with clinicopathologic variables, GC remained the only significant independent predictor of metastasis (HR=1.51, for each 0.1 unit increment, p<0.001). Conclusions: GC can better predict metastatic disease progression compared with clinical variables and may select among patients with adverse pathology a majority that is in fact at low risk for metastasis.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
小鹿不偷塔完成签到,获得积分10
刚刚
李爱国的应助被科研通管家采纳,获得10
刚刚
Akim的应助被科研通管家采纳,获得10
刚刚
傻子胡桃完成签到,获得积分10
刚刚
小星星维拉完成签到,获得积分10
刚刚
CodeCraft的应助被科研通管家采纳,获得10
刚刚
漂亮灵阳发布了新的文献求助10
刚刚
SciGPT的应助被科研通管家采纳,获得10
刚刚
1秒前
天天快乐的应助被科研通管家采纳,获得10
1秒前
小二郎的应助被科研通管家采纳,获得10
1秒前
1秒前
正直未来发布了新的文献求助10
1秒前
1秒前
1秒前
1秒前
2秒前
学霸颖完成签到,获得积分20
2秒前
桐桐的应助被樊焕焕采纳,获得10
2秒前
斯文败类的应助被张智磊采纳,获得10
3秒前
极限001的应助被科研蚂蚁采纳,获得30
3秒前
4秒前
KK发布了新的文献求助10
4秒前
4秒前
zjc完成签到,获得积分10
4秒前
yfn完成签到,获得积分10
7秒前
7秒前
包容映安发布了新的文献求助10
8秒前
8秒前
阿狸完成签到,获得积分10
8秒前
w7完成签到 ,获得积分10
8秒前
隐形曼青的应助被hyfwkd采纳,获得30
8秒前
8秒前
9秒前
9秒前
9秒前
9秒前
PENGQIDU完成签到 ,获得积分10
9秒前
CaliU发布了新的文献求助10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175262
求助须知:如何正确求助?哪些是违规求助? 9567017
关于积分的说明 21789663
捐赠科研通 7769695
什么是DOI,文献DOI怎么找? 3431840
关于科研通互助平台的介绍 2556124
邀请新用户注册赠送积分活动 2477241